Ben Franklin Technology Partners of Southeastern Pennsylvania

Avisi Technologies Inc. is focused on developing innovative solutions to combat glaucoma, a leading cause of irreversible blindness. The company has created VisiPlate, a next-generation aqueous shunt designed for mid to late-stage glaucoma treatment. This product is notable for its ultrathin design, being 20 times thinner than a human hair, which facilitates a less invasive insertion procedure that reduces operating time and simplifies follow-up care. VisiPlate is constructed from alumina, a material recognized for its use in hip replacements, thus ensuring biocompatibility. Founded in 2017 and headquartered in Philadelphia, Pennsylvania, Avisi Technologies aims to address the challenges associated with current glaucoma treatments, including patient non-compliance and post-operative complications, ultimately striving to prevent blindness in affected individuals.

Kognition LLC designs and develops enterprise software solution for real estate property managers and security operators. The company's platform uses artificial intelligence and machine learning to allow buildings to see, think, act, and learn on their own responding to security, property activities, surveillance, logistics, environmental, and maintenance issues. The product includes SuperGuard solution which combines live security camera footage with sensor data to detect security threats. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.

Optical Inventory Solutions is the creators of ViewVax.ViewVax is the industry leader in automated vaccine inventory. ViewVax’s simple and seamless design fits into a preexisting medical refrigerator allowing hospitals, clinics, and doctors’ offices the opportunity to utilize and organize their current medical refrigerators while integrating the automated inventory solution hardware and software. ViewVax’s web-connected, camera counts on-hand vaccine inventory, allowing for automatic reordering, reduced inventory levels, and easy identification of vaccines.

Avisi Technologies Inc. is focused on developing innovative solutions to combat glaucoma, a leading cause of irreversible blindness. The company has created VisiPlate, a next-generation aqueous shunt designed for mid to late-stage glaucoma treatment. This product is notable for its ultrathin design, being 20 times thinner than a human hair, which facilitates a less invasive insertion procedure that reduces operating time and simplifies follow-up care. VisiPlate is constructed from alumina, a material recognized for its use in hip replacements, thus ensuring biocompatibility. Founded in 2017 and headquartered in Philadelphia, Pennsylvania, Avisi Technologies aims to address the challenges associated with current glaucoma treatments, including patient non-compliance and post-operative complications, ultimately striving to prevent blindness in affected individuals.

Avisi Technologies Inc. is focused on developing innovative solutions to combat glaucoma, a leading cause of irreversible blindness. The company has created VisiPlate, a next-generation aqueous shunt designed for mid to late-stage glaucoma treatment. This product is notable for its ultrathin design, being 20 times thinner than a human hair, which facilitates a less invasive insertion procedure that reduces operating time and simplifies follow-up care. VisiPlate is constructed from alumina, a material recognized for its use in hip replacements, thus ensuring biocompatibility. Founded in 2017 and headquartered in Philadelphia, Pennsylvania, Avisi Technologies aims to address the challenges associated with current glaucoma treatments, including patient non-compliance and post-operative complications, ultimately striving to prevent blindness in affected individuals.

Kognition LLC designs and develops enterprise software solution for real estate property managers and security operators. The company's platform uses artificial intelligence and machine learning to allow buildings to see, think, act, and learn on their own responding to security, property activities, surveillance, logistics, environmental, and maintenance issues. The product includes SuperGuard solution which combines live security camera footage with sensor data to detect security threats. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.

Cognitive Operational Systems, LLC, based in Philadelphia, Pennsylvania, specializes in developing inventory management solutions for the retail sector through the use of robotics, artificial intelligence, and computer vision. Founded in 2012, the company’s technology enables robots to efficiently navigate retail environments, managing inventory, ensuring compliance with planograms and promotions, and providing indoor localization and navigation. Additionally, it offers mapping capabilities that detail store layouts and architecture. By leveraging university research, Cognitive Operational Systems aims to bridge the gap between academic advancements and practical applications in the fields of artificial intelligence and machine perception.

Vy Corporation is a software development company based in Wayne, Pennsylvania, specializing in shape detection and object analysis for the medical imaging market. The company offers cloud-based services, including CytoSavvy.com, which utilizes patented technology to identify and analyze clusters of cells in various biopsies, enhancing the capabilities of pathologists and medical researchers. Another product, VectorSavvy.com, provides users with access to advanced image analysis tools, enabling them to upload and evaluate images effectively. Vy Corporation's mission is to improve the efficiency and reliability of data collection and analysis in medical diagnostics, ultimately aiding in the identification of complex cell structures. Through its innovative software solutions, Vy aims to streamline the process of analyzing medical imagery, thereby supporting better research outcomes in the healthcare sector.

EyeIC, Inc. develops and commercializes imaging technologies for medical applications. The company serves eye care professionals and eye clinics. It offers MatchedFlicker, a device for monitoring the advent and progression of glaucoma through change detection in time series retinal photographs. The company's software works by aligning and registering two images of the same object taken at different points in time, and then generating a superimposed view that is alternated back and forth. The company was founded in 2004 and is based in Wayne, Pennsylvania.

Acuity Pharmaceuticals is a pharmaceutical company based in Philadelphia, Pennsylvania, established in 2007. It specializes in the treatment and prevention of ophthalmic diseases, particularly focusing on age-related macular degeneration (AMD) and diabetic retinopathy (DR). The company is developing small interfering RNA compounds aimed at addressing vision loss associated with these conditions. One of its key products, Cand5, is a clinical compound designed to inhibit vascular endothelial growth factor, thereby targeting adult vision loss. In June 2011, Acuity Pharmaceuticals was acquired by OPKO Health, enhancing its capabilities in the ophthalmic market.